1 EXHIBIT 10.17 {*} THE REDACTED PORTIONS INDICATED BY THIS SYMBOL ARE THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST AND HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. EXCLUSIVE LICENSE AGREEMENT THIS LICENSE AGREEMENT...Exclusive License Agreement • September 6th, 2001 • Atherogenics Inc • Pharmaceutical preparations • Georgia
